Literature DB >> 21378382

Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.

D Hunter Best1, Cecily Vaughn, Jamie McDonald, Kristy Damjanovich, James R Runo, Jason M Chibuk, Pinar Bayrak-Toydemir.   

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder caused by mutations in the ACVRL1, ENG, and SMAD4 genes. HHT is commonly characterised by small arteriovenous malformations (AVMs) known as telangiectasias of the skin, oral or gastrointestinal mucosa, as well as larger AVMs of solid organs (lungs, liver, brain). However, the manifestations of HHT are extremely variable. Two patients with no family history of HHT and strikingly different clinical presentations, who are mosaic for mutations in the ACVRL1 or ENG gene, are reported here. These cases represent the first report of mosaicism in patients clinically affected with classical HHT and pulmonary arterial hypertension, and suggest the need for awareness of mosaicism when performing clinical testing for this disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21378382     DOI: 10.1136/jmg.2010.088286

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Endothelial chromosome 13 deletion in congenital heart disease-associated pulmonary arterial hypertension dysregulates SMAD9 signaling.

Authors:  Kylie M Drake; Suzy A Comhair; Serpil C Erzurum; Rubin M Tuder; Micheala A Aldred
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

Review 2.  A genomic view of mosaicism and human disease.

Authors:  Leslie G Biesecker; Nancy B Spinner
Journal:  Nat Rev Genet       Date:  2013-05       Impact factor: 53.242

3.  Genetic Insights into Cerebrovascular Disorders: A Comprehensive Review.

Authors:  Fawaz Al-Mufti; Ahmed Alkanaq; Krishna Amuluru; Rolla Nuoman; Ahmed Abdulrazzaq; Tamarah Sami; Halla Nuoaman; Caroline Hayes-Rosen; Charles J Prestigiacomo; Chirag D Gandhi
Journal:  J Vasc Interv Neurol       Date:  2017-10

Review 4.  Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia.

Authors:  Akiko Hata; Giorgio Lagna
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 5.  ALK1 signaling in development and disease: new paradigms.

Authors:  Beth L Roman; Andrew P Hinck
Journal:  Cell Mol Life Sci       Date:  2017-09-04       Impact factor: 9.261

Review 6.  'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.

Authors:  Emilia M Swietlik; Matina Prapa; Jennifer M Martin; Divya Pandya; Kathryn Auckland; Nicholas W Morrell; Stefan Gräf
Journal:  Genes (Basel)       Date:  2020-11-26       Impact factor: 4.096

7.  Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management.

Authors:  Adrienne M Hammill; Katie Wusik; Raj S Kasthuri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 8.  Genetics of brain arteriovenous malformations and cerebral cavernous malformations.

Authors:  Hiroki Hongo; Satoru Miyawaki; Yu Teranishi; Daiichiro Ishigami; Kenta Ohara; Yu Sakai; Daisuke Shimada; Motoyuki Umekawa; Satoshi Koizumi; Hideaki Ono; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Hum Genet       Date:  2022-07-13       Impact factor: 3.755

9.  Neonatal bilateral cerebral high flow fistulae leading to detection of a HHT-family carrier.

Authors:  Hortensia Alvarez; Muhammad H Niazi; Joshua Loewenstein; Carolyn S Quinsey
Journal:  Interv Neuroradiol       Date:  2020-12-22       Impact factor: 1.764

Review 10.  Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.

Authors:  Rajiv D Machado; Laura Southgate; Christina A Eichstaedt; Micheala A Aldred; Eric D Austin; D Hunter Best; Wendy K Chung; Nicola Benjamin; C Gregory Elliott; Mélanie Eyries; Christine Fischer; Stefan Gräf; Katrin Hinderhofer; Marc Humbert; Steven B Keiles; James E Loyd; Nicholas W Morrell; John H Newman; Florent Soubrier; Richard C Trembath; Rebecca Rodríguez Viales; Ekkehard Grünig
Journal:  Hum Mutat       Date:  2015-10-12       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.